AbbVie (ABBV) Announces FDA Approval of VUITY 1.25%, the First and Only Eye Drop to Treat Presbyopia
Go back to AbbVie (ABBV) Announces FDA Approval of VUITY 1.25%, the First and Only Eye Drop to Treat Presbyopia| AbbVie (NYSE: ABBV) | Delayed: 234.76 +4.75 (2.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $230.01 | 52 Week High | $68.12 | |||
| Open | $232.97 | 52 Week Low | $50.71 | |||
| Day High | $235.31 | P/E | 50.92 | |||
| Day Low | $231.30 | EPS | $4.61 | |||
| Volume | 7,493,067 | |||||
